Hirotoshi Fukutsuka

Title: Hirotoshi Fukutsuka: Innovator in Human Serum Albumin Production

Introduction

Hirotoshi Fukutsuka is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of human serum albumin. With a total of 2 patents, his work has the potential to impact medical and pharmaceutical applications.

Latest Patents

Fukutsuka's latest patents include a method for producing human serum albumin using a fatty acid supplemented medium. This innovative approach involves cultivating a genetically engineered host in a medium containing fatty acids with 10 to 26 carbon atoms. The invention significantly enhances the production of human serum albumin. Another patent focuses on inhibiting the coloration of human serum albumin. This method utilizes gene manipulation technology to separate coloring contaminants from the serum albumin before they can bind, ensuring a purer product.

Career Highlights

Hirotoshi Fukutsuka is currently associated with The Green Cross Corporation, where he continues to advance his research and development efforts. His work is pivotal in enhancing the efficiency and quality of human serum albumin production, which is crucial for various medical treatments.

Collaborations

Fukutsuka collaborates with esteemed colleagues such as Kaoru Kobayashi and Takao Ohmura. Their combined expertise fosters an environment of innovation and progress in their respective fields.

Conclusion

Hirotoshi Fukutsuka's contributions to biotechnology, particularly in the production of human serum albumin, highlight his role as a significant inventor. His innovative methods and collaborations continue to pave the way for advancements in medical science.